Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Works matching AU Gonugunta, Amrit S.
Results: 6
1
2
Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
3
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 9, p. 2169, doi. 10.1007/s00262-022-03151-2
- By:
- Publication type:
- Article
4
Antibiotic Prescriptions in Lung Cancer and Melanoma Populations: Differences With Potential Clinical Implications in the Immunotherapy Era.
- Published in:
- Clinical Lung Cancer, 2023, v. 24, n. 1, p. 11, doi. 10.1016/j.cllc.2022.09.005
- By:
- Publication type:
- Article
5
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1327, doi. 10.3390/cancers14051327
- By:
- Publication type:
- Article
6
Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1197, doi. 10.1111/bjh.19633
- By:
- Publication type:
- Article